Key to evidence statements and grades of recommendations
Levels of evidence | |
1++ | High quality meta-analyses, systematic reviews of randomised controlled trials (RCTs) or RCTs with a very low risk of bias |
1+ | Well-conducted meta-analyses, systematic reviews or RCTs with a low risk of bias |
1− | Meta-analyses, systematic reviews or RCTs with a high risk of bias |
2++ |
|
2+ | Well-conducted case–control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal |
2− | Case–control or cohort studies with a high risk of confounding or bias and a significant risk that the relationship is not causal |
3 | Non-analytic studies (eg, case reports, case series) |
4 | Expert opinion |
Grades of recommendations | |
A | At least one meta-analysis, systematic review or RCT rated as 1++ and directly applicable to the target population; or A body of evidence consisting principally of studies rated as 1+, directly applicable to the target population, and demonstrating overall consistency of results |
B | A body of evidence including studies rated as 2++, directly applicable to the target population, and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 1++ or 1+ |
C | A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 2++ |
D | Evidence level 3 or 4; or Extrapolated evidence from studies rated as 2+ |
Good practice points | |
√ | Recommended best practice based on the clinical experience of the guideline development group |